Degussa divestments complete

- Last updated on GMT

Related tags: Chemistry, Degussa

German chemicals company Degussa has sold its Frankfurt/Main-based
biopharmaceutical company Zentaris to Canadian firm AEterna
Laboratories for approximately €50 million, the company said last
week. The move marks the much-talked about transformation to a pure
speciality chemicals company.

German chemicals company Degussa has sold its Frankfurt/Main-based biopharmaceutical company Zentaris to Canadian firm AEterna Laboratories for approximately €50 million, the company said last week. The move is seen as part of its focus on speciality chemicals.

With the sale of Zentaris completed, Degussa has now divested the last of the activities of ASTA Medica.

Professor Utz-Hellmuth Felcht, management board chairman of Degussa, said the sale of Zentaris marked the transformation of Degussa into a 'pure speciality chemicals company'. Degussa is hoping to tap further market potential in the speciality chemicals sector, with activities in the Specialty Polymers and Health & Nutrition divisions.

Zentaris, established at the beginning of 2001 as a carve out of ASTA Medica, expects to report sales in the order of €21 million for the financial year 2002. The company specialises in innovative pharmaceutical products, particularly in tumour and hormone research. Æterna Laboratories is a late-stage biopharmaceutical company with a primary emphasis on cancer.

The chairman of Germany's third-largest chemical company also said in a statement that the company has made 'decisive progress' in the strengthening of core operations and in restructuring activities. Restructuring and process optimisation will continue in the future, with the aim of cutting 4,000 jobs globally by 2004.

In fiscal 2001, Degussa generated operating profits of more than €1 billion.

Related topics: Suppliers, Antioxidants/carotenoids

Related products

show more

HydroCurc + Fe = Smart Formula

HydroCurc + Fe = Smart Formula

Gencor | 02-Mar-2021 | Clinical Study

Iron deficiency is the most prevalent micronutrient deficiency in the world and can have impacts on physical and mental health. A critical micronutrient...

Mom and baby:  From pre-natal to pre-teen

Mom and baby: From pre-natal to pre-teen

Kemin Human Nutrition and Health | Recorded the 24-Nov-2020 | Webinar

Nutrition during pregnancy, lactation, infancy and early childhood is known to induce long-term effects on later health of the child. 

The...

Related suppliers

Follow us

Products

View more

Webinars